High genotypic diversity among methicillin-resistant Staphylococcus pseudintermedius isolated from canine infections in Denmark
Open Access
- 29 June 2016
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 131
Abstract
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) has emerged globally in companion animals in the last decade. In Europe, the multidrug-resistant sequence type (ST)71 is widespread, but recently other clones have appeared. The objective of this study was to examine genotypic diversity and antimicrobial resistance of clinical MRSP isolates obtained from dogs, including dogs sampled on multiple occasions, in Denmark over a six-year period. For that purpose a total of 46 clinical MRSP isolates obtained from 36 dogs between 2009 and 2014 were subjected to antimicrobial susceptibility testing, multilocus-sequence typing (MLST) and SCCmec typing. Twenty-three sequence types were identified with ST71, mostly associated with SCCmec II-III, as the most common occurring in 13 dogs. Among the remaining 33 isolates, 19 belonged to clonal complex (CC)258 comprising ST258-SCCmec IV and its single- and double-locus variants. These were susceptible to 4–7 of the 22 antibiotics tested, whereas CC71 isolates were susceptible to only 2–5 antibiotics. Clone-specific differences were especially pronounced for fluoroquinolones and aminoglycosides with most CC71 isolates being resistant and almost all CC258 isolates being susceptible. Sixteen of the 19 CC258 isolates had oxacillin MICs of 0.5 g/L, whereas MICs for CC71 isolates were consistently above 4 g/L. Four of five dogs representing multiple isolates had distinct STs on different sampling events. The overall genotypic diversity of MRSP is high in Denmark indicating multiple acquisitions of SCCmec into distinct clones, and mutational evolution, which appears to be particularly rapid for certain ancestral clones such as ST258. ST71-SCCmec II-III is the most common MRSP lineage and is typically multidrug-resistant. CC258-SCCmec IV isolates, which emerged in Denmark since 2012, display susceptibility to a wider range of antimicrobials. The isolation of distinct STs in individual dogs over time suggests repeated exposure or short-term genetic evolution of MRSP clones within patients.Keywords
Funding Information
- internal funding
This publication has 23 references indexed in Scilit:
- Changes in the Population of Methicillin-Resistant Staphylococcus pseudintermedius and Dissemination of Antimicrobial-Resistant Phenotypes in the NetherlandsJournal of Clinical Microbiology, 2016
- Methicillin‐resistantStaphylococcus pseudintermedius(MRSP) from healthy dogs in Norway – occurrence, genotypes and comparison to clinicalMRSPMicrobiologyopen, 2015
- Isolation of coagulase-positive staphylococci from bitches’ colostrum and milk and genetic typing of methicillin-resistant Staphylococcus pseudintermedius strainsBMC Veterinary Research, 2015
- Enhanced adherence of methicillin-resistant Staphylococcus pseudintermedius sequence type 71 to canine and human corneocytesVeterinary Research, 2014
- Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in FranceJournal of Global Antimicrobial Resistance, 2014
- Staphylococcus pseudintermediusin the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicityVeterinary Dermatology, 2012
- Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermediusJournal of Antimicrobial Chemotherapy, 2012
- Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre studyJournal of Antimicrobial Chemotherapy, 2010
- Multiplex-PCR Method for Species Identification of Coagulase-Positive StaphylococciJournal of Clinical Microbiology, 2010
- Combination of Multiplex PCRs for Staphylococcal Cassette Chromosome mec Type Assignment: Rapid Identification System for mec , ccr , and MajorDifferences in Junkyard RegionsAntimicrobial Agents and Chemotherapy, 2007